25/06/2014 - Vanessa Morais and Bart De Strooper (VIB/KU Leuven) demonstrated how a defect in the PINK1 gene causes Parkinson’s disease.
20/03/2014 - Neuroscientists Vanessa Moraïs and Bart De Strooper from VIB and KU Leuven have demonstrated how a defect in the gene Pink1 results in Parkinson’s disease.
15/06/2013 - How competitive is VIB neuroscience research?
23/05/2013 - Technical comment of Bart De Strooper on the article about bexarotene as a potential Alzheimer’s drug published in Science approximately a year ago.
01/02/2013 - On Monday 4 February, Dennis J. Selkoe and five other “brain teasers” will receive an honorary doctorate from the KU Leuven.
14/12/2012 - Until now, it was not clearly understood how LRRK2 regulated synaptic function necessary in the treatment of Parkinson’s. This situation has now been remedied by Samer Matta from the Bart De Strooper lab, in collaboration with the Patrik Verstreken lab.
02/12/2012 - Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer’s disease.
31/08/2012 - 2 to 3 % of the children are born with an intellectual disability. VIB researchers at KU Leuven show that increased production of the HUWE1 protein is the cause in some patients.
18/11/2010 - VIB researchers Peter Carmeliet and Bart De Strooper have both been awarded Advanced Grants from the European Research Council. ERC Advanced Grants are the most prestigious European research grants, spanning a period of 5 years.
11/10/2010 - VIB and Janssen R&D Neuroscience entered into an open-innovation collaboration to develop novel therapeutics for psychiatric and neurodegenerative disorders.
14/09/2010 - For the first time in Belgium, a private partner and an academic research institution have established a fund for research into a disease.
10/12/2009 - Researchers have discovered a new explanation for differences in the severity of mental illness in males. The more excess copies of a certain gene, the more serious the handicap.
19/04/2009 - VIB scientists connected to the K.U.Leuven have identified a molecule that can form the basis for a new therapy for Alzheimer’s disease. This is the first step toward a medicine that could actually stop the progress of Alzheimer’s.
12/02/2009 - VIB scientists connected to the Center for Human Genetics (K.U.Leuven) have demonstrated that a particular protein is extremely well suited to be a target for a new medicine against Alzheimer’s disease.
16/09/2008 - Revealing the regulating mechanism behind signal transduction in the brain
14/07/2008 - Incorrectly cleaved protein leads to schizophrenia
22/04/2008 - Ground-breaking new insight into the development of Alzheimer’s disease
29/02/2008 - Bart De Strooper (VIB, K.U.Leuven) has been playing a prominent role in researching the processes that underlie Alzheimer's disease and now he receives the MetLife Foundation’s USD 200,000 Alzheimer Prize.
24/01/2008 - Discovery of new cause of mental retardation simplifies search for treatments
14/07/2006 - Scientists have now discovered the function of the PARL protein. By studying mice that are unable to produce PARL, the researchers have discovered the significance of this protein in controlled cell death